|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.957
|
|
|
|
somatic muscle development
|
GO:0007525 |
1 |
0.801
|
|
|
|
glycolytic process
|
GO:0006096 |
17 |
0.761
|
|
|
|
somitogenesis
|
GO:0001756 |
2 |
0.749
|
|
|
|
single organism carbohydrate metabolic process
|
GO:0044723 |
193 |
0.650
|
|
|
|
single organism carbohydrate catabolic process
|
GO:0044724 |
33 |
0.622
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.612
|
|
|
|
nucleotide biosynthetic process
|
GO:0009165 |
109 |
0.471
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
81 |
0.437
|
|
|
|
myoblast fusion
|
GO:0007520 |
1 |
0.427
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.395
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.345
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.332
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
36 |
0.284
|
|
|
|
anion transport
|
GO:0006820 |
161 |
0.235
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
231 |
0.191
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.190
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.188
|
|
|
|
muscle cell cellular homeostasis
|
GO:0046716 |
3 |
0.160
|
|
|
|
pyruvate metabolic process
|
GO:0006090 |
26 |
0.152
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.152
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.145
|
|
|
|
ribonucleoside biosynthetic process
|
GO:0042455 |
25 |
0.144
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.136
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.136
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
188 |
0.129
|
|
|
|
ribonucleoside monophosphate biosynthetic process
|
GO:0009156 |
17 |
0.112
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.111
|
|
|
|
atp biosynthetic process
|
GO:0006754 |
11 |
0.111
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.108
|
|
|
|
replicative cell aging
|
GO:0001302 |
3 |
0.108
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.108
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.104
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.095
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
68 |
0.093
|
|
|
|
myosin filament organization
|
GO:0031033 |
2 |
0.089
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.089
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.086
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.083
|
|
|
|
microtubule based process
|
GO:0007017 |
210 |
0.082
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.080
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.079
|
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.077
|
|
|
|
glomerular mesangial cell development
|
GO:0072144 |
1 |
0.076
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.075
|
|
|
|
cellular response to hydrogen peroxide
|
GO:0070301 |
37 |
0.074
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.074
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.072
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.071
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.070
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
79 |
0.069
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.067
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.065
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.065
|
|
|
|
response to virus
|
GO:0009615 |
126 |
0.064
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.063
|
|
|
|
fructose metabolic process
|
GO:0006000 |
3 |
0.063
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
82 |
0.062
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.062
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.061
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.061
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
117 |
0.060
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.060
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.057
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
163 |
0.057
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.056
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.055
|
|
|
|
cellular aldehyde metabolic process
|
GO:0006081 |
20 |
0.055
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.054
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.054
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.054
|
|
|
|
nucleoside triphosphate biosynthetic process
|
GO:0009142 |
20 |
0.054
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.054
|
|
|
|
system process
|
GO:0003008 |
349 |
0.053
|
Human |
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.053
|
|
|
|
muscle contraction
|
GO:0006936 |
73 |
0.052
|
Human |
|
|
unsaturated fatty acid biosynthetic process
|
GO:0006636 |
21 |
0.050
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.049
|
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
2 |
0.049
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
227 |
0.048
|
|
|
|
negative regulation of sequestering of calcium ion
|
GO:0051283 |
41 |
0.047
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.047
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.047
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.045
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.045
|
|
|
|
positive regulation of binding
|
GO:0051099 |
45 |
0.045
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.045
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.044
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.043
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.043
|
|
|
|
aging
|
GO:0007568 |
66 |
0.043
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.043
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
115 |
0.043
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.043
|
|
|
|
renal interstitial fibroblast development
|
GO:0072141 |
1 |
0.042
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.041
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.041
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.040
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.040
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.040
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
84 |
0.039
|
|
|
|
regulation of mitochondrial membrane permeability involved in apoptotic process
|
GO:1902108 |
18 |
0.039
|
|
|
|
hexose metabolic process
|
GO:0019318 |
55 |
0.039
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.038
|
|
|
|
sex differentiation
|
GO:0007548 |
45 |
0.038
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.037
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.037
|
|
|
|
muscle system process
|
GO:0003012 |
81 |
0.037
|
Human |
|
|
translesion synthesis
|
GO:0019985 |
8 |
0.036
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
2 |
0.036
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.036
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.036
|
|
|
|
vitamin metabolic process
|
GO:0006766 |
26 |
0.035
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.035
|
|
|
|
response to superoxide
|
GO:0000303 |
6 |
0.035
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.035
|
|
|
|
growth
|
GO:0040007 |
202 |
0.035
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.034
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
17 |
0.034
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
128 |
0.034
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.034
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
72 |
0.034
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.034
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.033
|
|
|
|
positive regulation of protein secretion
|
GO:0050714 |
60 |
0.033
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.033
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.033
|
|
|
|
cofactor biosynthetic process
|
GO:0051188 |
31 |
0.033
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.033
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.032
|
|
|
|
positive regulation of transporter activity
|
GO:0032411 |
32 |
0.032
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
72 |
0.031
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.031
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
72 |
0.031
|
|
|
|
hydrogen peroxide metabolic process
|
GO:0042743 |
20 |
0.031
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.030
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
84 |
0.030
|
|
|
|
base excision repair
|
GO:0006284 |
21 |
0.030
|
|
|
|
negative regulation of protein phosphatase type 2b activity
|
GO:0032513 |
2 |
0.030
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.029
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.029
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.029
|
|
|
|
rna catabolic process
|
GO:0006401 |
71 |
0.029
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.029
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.028
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.028
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.028
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.027
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.027
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.026
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.026
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.026
|
|
|
|
fructose 1 6 bisphosphate metabolic process
|
GO:0030388 |
5 |
0.026
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.026
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.026
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.025
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.025
|
|
|
|
mitochondrial outer membrane permeabilization
|
GO:0097345 |
15 |
0.025
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.024
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.024
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.024
|
|
|
|
nucleoside biosynthetic process
|
GO:0009163 |
26 |
0.024
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.024
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.024
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.023
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.023
|
|
|
|
action potential
|
GO:0001508 |
34 |
0.023
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
84 |
0.023
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.023
|
|
|
|
mitochondrial membrane organization
|
GO:0007006 |
40 |
0.023
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.023
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.022
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.022
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.022
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.022
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.022
|
|
|
|
meiosis i
|
GO:0007127 |
4 |
0.021
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.021
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.021
|
|
|
|
myotube differentiation
|
GO:0014902 |
22 |
0.021
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
180 |
0.021
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.021
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.021
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.021
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.021
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.021
|
|
|
|
gonad development
|
GO:0008406 |
34 |
0.021
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
24 |
0.020
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.020
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.020
|
|
|
|
establishment of nucleus localization
|
GO:0040023 |
1 |
0.020
|
|
|
|
deoxyribose phosphate metabolic process
|
GO:0019692 |
6 |
0.020
|
|
|
|
response to activity
|
GO:0014823 |
0 |
0.019
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.019
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.019
|
|
|
|
response to acid chemical
|
GO:0001101 |
66 |
0.019
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.019
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.019
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.019
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.019
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.019
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.019
|
|
|
|
glucan metabolic process
|
GO:0044042 |
22 |
0.019
|
|
|
|
reproductive system development
|
GO:0061458 |
56 |
0.018
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.018
|
|
|
|
calcium ion transport
|
GO:0006816 |
147 |
0.018
|
|
|
|
embryo development ending in birth or egg hatching
|
GO:0009792 |
34 |
0.018
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
88 |
0.018
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.018
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
59 |
0.018
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
87 |
0.018
|
|
|
|
fear response
|
GO:0042596 |
0 |
0.018
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
125 |
0.018
|
|
|
|
positive regulation of transmembrane transport
|
GO:0034764 |
41 |
0.018
|
|
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.018
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
59 |
0.018
|
|
|
|
response to mechanical stimulus
|
GO:0009612 |
51 |
0.018
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.018
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.017
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.017
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.017
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.017
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.017
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.017
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.017
|
|
|
|
cell part morphogenesis
|
GO:0032990 |
137 |
0.017
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.017
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.016
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.016
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
63 |
0.016
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.016
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.016
|
|
|
|
reproduction
|
GO:0000003 |
63 |
0.016
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.016
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.016
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
67 |
0.016
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.016
|
|
|
|
purine ribonucleoside biosynthetic process
|
GO:0046129 |
23 |
0.016
|
|
|
|
regulation of viral process
|
GO:0050792 |
103 |
0.016
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.016
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.016
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.015
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
4 |
0.015
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.015
|
|
|
|
negative regulation of camp mediated signaling
|
GO:0043951 |
4 |
0.015
|
|
|
|
urate metabolic process
|
GO:0046415 |
11 |
0.015
|
|
|
|
neural tube formation
|
GO:0001841 |
3 |
0.015
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.015
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
149 |
0.015
|
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.015
|
|
|
|
glycosyl compound biosynthetic process
|
GO:1901659 |
27 |
0.015
|
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
186 |
0.015
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.015
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.015
|
|
|
|
response to hydrogen peroxide
|
GO:0042542 |
40 |
0.015
|
|
|
|
single organism reproductive process
|
GO:0044702 |
98 |
0.015
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.014
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.014
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.014
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.014
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.014
|
|
|
|
negative regulation of translation
|
GO:0017148 |
37 |
0.014
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.014
|
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
101 |
0.014
|
|
|
|
positive regulation of growth
|
GO:0045927 |
58 |
0.014
|
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
4 |
0.014
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.014
|
|
|
|
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
|
GO:1901029 |
4 |
0.014
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
74 |
0.014
|
|
|
|
organic anion transport
|
GO:0015711 |
103 |
0.014
|
|
|
|
cellular respiration
|
GO:0045333 |
21 |
0.014
|
|
|
|
peptidyl cysteine modification
|
GO:0018198 |
9 |
0.014
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.014
|
|
|
|
striated muscle cell differentiation
|
GO:0051146 |
43 |
0.014
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
119 |
0.013
|
|
|
|
defense response to other organism
|
GO:0098542 |
129 |
0.013
|
|
|
|
purine nucleoside monophosphate biosynthetic process
|
GO:0009127 |
16 |
0.013
|
|
|
|
protein secretion
|
GO:0009306 |
98 |
0.013
|
|
|
|
lipid transport
|
GO:0006869 |
90 |
0.013
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.013
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.013
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.013
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
190 |
0.013
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
32 |
0.013
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.013
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.013
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.013
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.013
|
|
|
|
regulation of mitochondrial membrane permeability
|
GO:0046902 |
25 |
0.013
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
35 |
0.013
|
|
|
|
regulation of peptidyl serine phosphorylation
|
GO:0033135 |
50 |
0.013
|
|
|
|
positive regulation of synaptic transmission
|
GO:0050806 |
4 |
0.012
|
|
|
|
regulation of transmembrane transporter activity
|
GO:0022898 |
74 |
0.012
|
|
|
|
regulation of release of cytochrome c from mitochondria
|
GO:0090199 |
29 |
0.012
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.012
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.012
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.012
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
90 |
0.012
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
59 |
0.012
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
37 |
0.012
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
108 |
0.012
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.012
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.012
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.012
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.012
|
|
|
|
developmental growth
|
GO:0048589 |
48 |
0.012
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.011
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.011
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.011
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.011
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
2 |
0.011
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.011
|
|
|
|
peptidyl cysteine oxidation
|
GO:0018171 |
1 |
0.011
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
41 |
0.011
|
|
|
|
cytokine secretion
|
GO:0050663 |
64 |
0.011
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.011
|
|
|
|
ribonucleoside bisphosphate biosynthetic process
|
GO:0034030 |
4 |
0.011
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.011
|
|
|
|
lipid storage
|
GO:0019915 |
28 |
0.011
|
|
|
|
negative regulation of phosphatase activity
|
GO:0010923 |
61 |
0.011
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
177 |
0.011
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.011
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.011
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.011
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.011
|
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
30 |
0.011
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.011
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.011
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
44 |
0.011
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.011
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.011
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.010
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
169 |
0.010
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.010
|
|
|
|
ribonucleoprotein complex biogenesis
|
GO:0022613 |
116 |
0.010
|
|
|
|
negative regulation of response to dna damage stimulus
|
GO:2001021 |
33 |
0.010
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.010
|
|
|
|
head development
|
GO:0060322 |
108 |
0.010
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.010
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.010
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.010
|
|
|
|
nuclear import
|
GO:0051170 |
106 |
0.010
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.010
|
|
|
|
amide transport
|
GO:0042886 |
76 |
0.010
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.010
|
|
|
|
positive regulation of immune system process
|
GO:0002684 |
283 |
0.010
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.010
|
|